AbCellera Biologics Inc.NASDAQ: ABCL

AbCellera Announces Virtual Presentations at Investor Conferences in November

· Issued by AbCellera Biologics Inc. via Business Wire

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following virtual investor conferences:

  • Credit Suisse 30th Annual Virtual Healthcare Conference on Thursday, November 11 at 7:30 a.m. Pacific Time
  • Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16 at 10:20 a.m. Pacific Time
  • Piper Sandler 33rd Annual Virtual Healthcare Conference on Tuesday, November 30 (recorded and available on November 22)

Live audio webcasts of the Credit Suisse and Stifel presentations may be accessed through links that will be posted on AbCellera’s Investor Relations website. A replay of all three recordings will be available at the same location following the presentations.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com

Source: AbCellera Biologics Inc.

Media: Jessica Yingling, Ph.D.; [email protected], +1(236)521-6774 Business Development: Neil Berkley; [email protected], +1(604)559-9005 Investor Relations: Melanie Solomon; [email protected], +1(778)729-9116

Source: AbCellera Biologics Inc.

View original source (Business Wire)AbCellera Biologics Inc. on 6ix

Story so far

Earlier from AbCellera Biologics

Later from AbCellera Biologics

All AbCellera Biologics news releases